638 related articles for article (PubMed ID: 26293308)
1. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of ubiquilin-1 in the human hippocampus: association with neurofibrillary tangle pathology.
Mizukami K; Abrahamson EE; Mi Z; Ishikawa M; Watanabe K; Kinoshita S; Asada T; Ikonomovic MD
Neuropathology; 2014 Feb; 34(1):11-8. PubMed ID: 23869942
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
[TBL] [Abstract][Full Text] [Related]
6. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
7. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla).
Perez SE; Raghanti MA; Hof PR; Kramer L; Ikonomovic MD; Lacor PN; Erwin JM; Sherwood CC; Mufson EJ
J Comp Neurol; 2013 Dec; 521(18):4318-38. PubMed ID: 23881733
[TBL] [Abstract][Full Text] [Related]
9. Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition.
Giannakopoulos P; von Gunten A; Kövari E; Gold G; Herrmann FR; Hof PR; Bouras C
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):334-43. PubMed ID: 17442063
[TBL] [Abstract][Full Text] [Related]
10. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
[TBL] [Abstract][Full Text] [Related]
11. [Microtubule-associated protein30 (MAP30) and ubiquitin detected in neurofibrillary tangles of Alzheimer's disease brains].
Liu Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):11-3. PubMed ID: 10681783
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease.
Brion JP; Couck AM; Conreur JL
Neurodegeneration; 1995 Mar; 4(1):13-21. PubMed ID: 7600182
[TBL] [Abstract][Full Text] [Related]
13. Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.
Ikonomovic MD; Abrahamson EE; Uz T; Manev H; Dekosky ST
J Histochem Cytochem; 2008 Dec; 56(12):1065-73. PubMed ID: 18678882
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
15. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
16. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
17. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
18. Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.
Hunter S; Minett T; Polvikoski T; Mukaetova-Ladinska E; Brayne C;
Alzheimers Res Ther; 2015 Aug; 7(1):57. PubMed ID: 26315613
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology and cholinesterase expression in the brains of octogenarians and older.
Maxwell SP; Cash MK; Darvesh S
Chem Biol Interact; 2022 Sep; 364():110065. PubMed ID: 35872043
[TBL] [Abstract][Full Text] [Related]
20. A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients.
Furcila D; DeFelipe J; Alonso-Nanclares L
J Alzheimers Dis; 2018; 64(2):417-435. PubMed ID: 29914033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
